MedPath

Trial of Excision Versus Photodynamic Therapy in the Treatment of Bowen's Disease

Phase 4
Terminated
Conditions
Bowen's Disease
Interventions
Procedure: excision
Procedure: Photodynamic therapy
Registration Number
NCT00472706
Lead Sponsor
Catharina Ziekenhuis Eindhoven
Brief Summary

The purpose of this study is to identify the most optimal therapy for Bowen's disease: excision versus Photodynamic therapy.

Detailed Description

The study is a randomized clinical trial in which two treatment options for Bowen's disease, excision and photodynamic therapy, are compared on recurrence rate, cosmesis en expenses.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
65
Inclusion Criteria
  • Age > 18 years
  • Histological proven Bowen's disease on scalp, face, trunk, arms and legs
  • Informed Consent
Exclusion Criteria
  • Recurrent Bowen's disease
  • Anogenital or subungual Bowe's disease
  • Other skin malignancy in the same area
  • Porphyria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1excisionExcision
2Photodynamic therapyPhotodynamic therapy
Primary Outcome Measures
NameTimeMethod
recurrence ratetwo years
Secondary Outcome Measures
NameTimeMethod
cosmetic outcomeone year
© Copyright 2025. All Rights Reserved by MedPath